Abstract
Aggressive medical therapy is warranted to prevent morbidity and mortality that has long been associated with skull base osteomyelitis. Outcomes are now improved because of a better understanding of the pathophysiology of the disease process, improved diagnostic tests, and more effective antipseudomonal therapy.
MeSH terms
-
Aminoglycosides
-
Anti-Bacterial Agents / therapeutic use
-
Humans
-
Lactams
-
Osteomyelitis / drug therapy
-
Osteomyelitis / etiology
-
Osteomyelitis / pathology*
-
Otitis Externa / complications*
-
Otitis Externa / microbiology
-
Pseudomonas aeruginosa / isolation & purification
-
Skull Base / pathology*
Substances
-
Aminoglycosides
-
Anti-Bacterial Agents
-
Lactams